In a LPS-induced ALI (intratracheal), administration of α7 nAChR agonists could inhibit NF-κB activity in the BAL proinflammatory cells and reduce both TNF-α and MIP-2 levels in the BAL [5]. This evidence concerns the gene NFKB1 and acute respiratory distress syndrome.